Credits: Canva
A surprising rise in unplanned pregnancies among women taking popular weight-loss medications such as Ozempic, Wegovy, and Mounjaro has prompted global health authorities to issue a clear warning0- use effective contraception. The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has released its first public alert linking the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with potential contraceptive failure especially among overweight users relying on oral birth control.
With more than 40 pregnancy reports associated with these medications such as semaglutide-based injectables (Ozempic and Wegovy), liraglutide (Saxenda and Victoza), and tirzepatide (Mounjaro) the data has raised alarm within the international medical community. The unforeseen side effect is sparking a pressing debate regarding reproductive health, drug safety, and the unforeseen effects of "skinny jabs" that have gained immense popularity.
These drugs in question, such as Ozempic, Wegovy, and Mounjaro, are members of the GLP-1 RA drug class. Initially developed to manage Type 2 diabetes, these medications simulate the GLP-1 hormone to control insulin levels, delay digestion, and curb appetite.
Mounjaro, which acts on a second hormone (GIP), extends this mechanism even further by increasing sensitivity to insulin and offering even stronger control over appetite. These actions make the drugs extremely useful as weight losers—but they also modify digestion and hormone balance, potentially disrupting the absorption and metabolism of oral contraceptives, particularly among overweight patients.
The MHRA specifically states that Mounjaro can decrease oral contraceptive efficacy, especially in the first four weeks of treatment and following any increase in dosage. This is a major concern for women who use the pill as their method of birth control when on these injections.
Also Read: Do You Need More Protein Or Just The Right Kind? Dietician Explains How To Make Smarter Choices
The real-world consequences are starting to become more apparent. Social media groups such as the Facebook group "I Got Pregnant on Ozempic," which had over 750 participants in the past year, are full of anecdotal accounts from women who were surprised to find that they were pregnant after using precautions. "Ozempic babies" these pregnancies are generating new publicity for a once little-discussed side effect of these treatments for weight loss.
MHRA records indicate 26 cases of pregnancy associated with Mounjaro, eight with semaglutide (Ozempic and Wegovy), and nine with liraglutide (Saxenda and Victoza). Although not all cases indicated whether the pregnancy was unplanned, at least two did. The trend has health officials and clinicians reassessing how contraception is counselled and controlled in conjunction with these treatments.
The MHRA and similar medical agencies now fully recommend women taking these weight-loss injections to use safe contraception—ideally combining methods. Women are asked to engage in barrier methods such as condoms alongside oral contraceptives, especially when taking Mounjaro.
In addition, these drugs are also contraindicated during pregnancy, conception, or lactation. Since there is no long-term safety information, experts advise that GLP-1 RAs may be having unforeseen effects on fetal development. The MHRA advises women to discontinue using these drugs at least two months prior to trying to conceive so that the drug has been completely cleared from the body.
Healthcare providers are also being reminded to clearly convey these warnings at the time of prescribing and to make patients fully aware of the possible reproductive consequences of these potent drugs.
The world's popularity with weight-loss injectables is on the rise, fueled partly by endorsement from celebrities, social media buzz, and increasing recognition of obesity as a disease. But that increased usage has far surpassed public awareness of the drugs' side effects—especially those related to reproductive health.
Experts caution that off-label use of such drugs, like buying them from beauty salons or internet retailers without prescription, may open more women to unregulated risks. The MHRA insists these drugs are approved to deal with certain clinical conditions and must not be used for cosmetic weight loss only.
"They are not a weight loss quick fix," the MHRA said. "They have not been evaluated as safe for use for aesthetic purposes, and improper use could have serious health consequences, particularly in pregnancy."
Besides reproductive issues, GLP-1 RAs have been associated with a rare but severe complication: acute pancreatitis. The symptoms are chronic stomach pain that radiates to the back and doesn't resolve. Anyone with these symptoms should immediately consult a physician.
Prescription leaflets issued with the drugs now contain revised advice on pregnancy, contraception, and possible side effects. Both patients and healthcare professionals are asked to report any adverse effects through the MHRA's Yellow Card scheme, enabling monitoring of the safety of such widely used medicines in real-time.
Weight-loss medications such as Ozempic, Wegovy, and Mounjaro are changing lives by providing safe, health-approved solutions to obesity and diabetes. With great benefit, however, comes the burden of informed use. That means for women of childbearing age, it's necessary to know how such medications can affect fertility and the reliability of birth control.
If you are taking or thinking about taking GLP-1 medications, discuss with your doctor what kind of birth control is appropriate for you, and if pregnancy is in the cards, get off the drug well ahead of time.
While the potential of these drugs is great, their administration has to be based in science, safety, and full medical care—particularly when it comes to reproductive health.
(Credit-Canva)
While many people do not consider cancer to be a big cause of concern for young adults However, how many times have we heard of stories of young kids suffering with cancer and young adults who had to put their lives on hold due to unexpected cancer diagnoses? The increase in young adults with cancer is not a mere coincidence; a new study shows that the past decade has seen an increase in the number of early-onset gastrointestinal (GI) cancer cases.
New research published in the British Journal of Surgery shows a really worrying trend, they stated cancers of the stomach, intestines, and other digestive organs are increasing incredibly fast in people 50 and younger in the U.S. This isn't just a small increase; it's happening quicker than any other type of cancer in younger people. It's a big health concern for younger Americans.
The study points out that between 2010 and 2019, the number of GI cancer cases in young people jumped by almost 15%. While colon cancer is the most common of these early cancers, making up over half the cases worldwide, it's not the only one. Cancers of the pancreas, stomach, and esophagus are also becoming more common in younger individuals. This is extra concerning because when younger people get these cancers, they often act more aggressively, meaning they need more intense treatment, and sadly, their chances of survival can be similar to or even worse than older patients.
While most GI cancer cases are still in people aged 40 to 49, the increase is even steeper in younger age groups. For example, if you were born in 1990, you're twice as likely to get colon cancer and four times as likely to get rectal cancer compared to someone born in 1950. Data from the CDC (Centers for Disease Control and Prevention) confirms this, showing that colon cancer rates have more than tripled in teenagers (15-19) and almost doubled in young adults (20-24). Also, recent studies from 2018 to 2022 found that women saw bigger increases in several early-onset GI cancers:
Colon cancers: Went up by 5% each year for women, compared to 3.5% for men.
Esophageal cancers: Increased almost 6% yearly for women, versus 1% for men.
Stomach cancers: Rose about 4% each year for women, and less than 3% for men.
Small intestine cancers: Grew by 3.5% for women, and under 3% for men.
On top of that, the studies highlighted that Black, Hispanic, and Native American people are being affected much more by this rise in GI cancers.
Despite these alarming numbers, new guidelines that recommend colon cancer screening for healthy people starting at age 45 haven't been widely adopted. In fact, in 2021, only about 1 in 5 Americans aged 45 to 49 actually got screened.
Getting screened is super important! It's been proven to save lives by not only reducing the number of people who get colorectal cancer but also by lowering the number of deaths from it. Every time someone skips a screening, it's a lost chance to find cancer early when it's easier to treat, or even to prevent cancer entirely by finding and removing precancerous growths called polyps.
Several things can increase your risk of getting GI cancer, including being overweight, eating a lot of high-fat Western-style foods, having fatty liver disease, smoking, and drinking alcohol.
Researchers are now urging more studies to figure out why GI cancer rates are going up in younger adults. They're also pushing for better ways to prevent these cancers and find them early. More information is especially needed for pancreatic, stomach, and esophageal cancers. Raising awareness and educating people about these issues is vital because, as a group, digestive system cancers cause a significant number of cancer-related deaths in young adults both in the U.S. and around the world.
Credits: Canva
Every year, World Brain Day is marked to raise awareness around brain health and neurological conditions that often go undiagnosed or misunderstood. This year’s theme focuses on brain health and early detection, emphasizing how subtle signs—often brushed off as routine stress—may actually be the brain’s way of raising an alarm.
While stress-related fatigue, burnout, and tension headaches are all-too-common in today’s never-resting, always hustling world, experts warn that dismissing persistent or unusual neurological symptoms as “just stress” could delay diagnosis of something more serious, such as a brain tumor.
We spoke with Dr. Mukesh Kumar, Director and Head (Parkinson's Disease Unit), Neurosciences, Neurology, Max Super Speciality Hospital, Saket, to understand the difference between stress symptoms and potential red flags.
Headaches are the most common symptom people link with stress, but not all headaches are created equal.
Dr. Kumar explains, “A worst headache in the morning may be a feature of subarachnoid haemorrhage (SAH), which is a medical emergency. Stress headaches are usually mild to moderate and without vomiting. SAH is usually very severe and comes with nausea or vomiting.”
He adds that if your headache feels significantly different from your usual ones, especially if it’s persistent, worsening over time, or most intense after waking up, it’s worth seeking a neurological opinion.
Feeling mentally scattered, struggling to focus, or forgetting things easily? It could be burnout, but not always.
“Brain fog due to burnout is usually transient, affecting multiple domains and without any functional disability,” says Dr. Kumar. It’s often tied to sleep issues like delayed sleep initiation or fragmented rest.
On the other hand, “Cognitive disability related to a brain tumor may affect one or more specific cognitive domains, tends to persist, and comes with functional disability,” he adds. You may also notice seizures, limb weakness, or trouble with routine tasks.
Occasional clumsiness may seem harmless, especially during hectic workweeks. However, if it progresses to frequent falls, a noticeable decline in coordination, or needing support for routine tasks, don’t ignore it.
Dr. Kumar advises, “See a neurologist if there’s physical disability, frequent falls, need for support in walking, or significant reduction in your day-to-day functional efficiency.”
These may point to disturbances in the brain’s motor control centers, possibly caused by a tumor affecting balance and coordination.
Stress does affect mood, but a rapid and unexplained shift in personality could be neurological. “Sudden personality changes, if persistent for a few days to weeks, suggest early features of a brain tumor,” says Dr. Kumar.
So, if someone who’s usually calm becomes irritable, withdrawn, or impulsive with no clear reason—and these changes don’t go away, it’s time for a deeper evaluation.
Blurred vision, slurred speech, or trouble finding the right words after a long day might seem like signs of tiredness. But if these symptoms come and go—or worsen—don’t brush them off.
According to Dr. Kumar, watch out for “faster reaction or impulsive behaviour, neck and back pain, early morning back stiffness, fluctuating vision or speech issues, and disturbed sleep patterns.” These are neurological red flags that demand attention.
The key message this World Brain Day is simple: Don’t ignore what your brain is trying to tell you. While stress is real and widespread, persistent or unusual symptoms—especially if they’re affecting your daily life—deserve a professional checkup.
As Dr. Kumar sums it up, “Early detection can significantly improve outcomes in brain tumors. When in doubt, get it checked out.”
Credits: Canva
An j8-year-old Myrtle Beach boy has Lyme disease and his parents are doing everything they can to treat him, so he could have a "normal childhood", reports News13.
As per the National Library of Medicine, USA, Lyme disease, also known as Lyme borreliosis, is an infectious condition, which is transmitted through the bite of infected ticks. This is primarily caused by the spirochete bacterium Borrelia burgdorferi in the United States and various Borrelia species in Europe and Asia.
The parents, LeeAnn and Brian Kuhl, said that their son, Ben, one day came home with a tick bite on his belly button after a hike he went on four years go. He was four at that time.
The doctors had told the Kuhls that since Ben's tick bite did not have a bullseye on it, there was nothing to be concerned about. Therefore, Lyme disease was not even something in their mind. However, things changed soon, and Ben was diagnosed.
By the time he was diagnosed, the disease had spread to all Ben's organs, including his brain. He was only able to talk on some days, his motor functions also worsened. He now has a very painful inflammation, and spends most of his time indoors.
“You mourn the life that he was supposed to have, so you mourn the parent that you were supposed to be,” LeeAnn said.
The parents also share that his symptoms have affected his friendships with other children. “I see the frustration when he can’t play with them because they’re at a faster pace now than he is,” LeeAnn said. “It’s sad because, when they’re all goofing around, he wants to be in there, too, but he can’t talk to them.”
The National Library of Medicine notes that this disease typically develops in three stages: early localized, early disseminated, and late stage. Early signs often include a telltale “bull’s-eye” rash (erythema migrans), along with fever and fatigue.
Without treatment, the infection can spread, affecting the nervous system, heart, and joints. In its late stage, it may cause chronic arthritis and brain-related issues, highlighting the critical need for early detection and timely treatment.
However, the treatment is not cheap. The Kuhls told News13 that they spend hundreds of dollars per month and that not all his medicines are covered by insurance. In fact, Brian has started working two jobs, and is sill looking for more work.
The Kuhls told News13 that they have found a community in Myrtle Beach who are helping them with Ben's treatment.
“We had all these people coming to us and offering to pay for a month of supplements or offering services to him,” LeeAnn said. “Without them, we could not be where we are right now.”
While Ben will always be affected by this disease, there is a hope that he will eventually be in full remission. Till then, they are not giving up on their hopes to see their child healthy.
“He is going to be such a testimony on not giving up,” LeeAnn said. “We tell him every day, ‘you’re going to stand there one day, and you’re going to speak to a bunch of people who are going through something, and you’re going to tell them what God did for you.’”
The early signs shows somewhere between 3 to 30 days after tick bite, notes the Centers for Disease Control and Prevention, USA (CDC).
The signs and symptoms include:
Later signs, which may come after a month of being bitten, notes CDC are:
© 2024 Bennett, Coleman & Company Limited